Introduction {#section0005}
============

Avian influenza viruses (AIV) within the *Orthomyxoviridae* family have segmented, negative sense RNA genomes. These viruses, natural infectious agents of waterfowl and shorebirds, are classified according to their transmembrane hemagglutinin (HA) and neuraminidase (NA) glycoproteins ([@bib1], [@bib23], [@bib32], [@bib53]). Due to their incredibly broad avian host range, AIV strains have been isolated from many different species of birds including ducks, gulls, geese, psittacines and poultry ([@bib1], [@bib32]). AIV strains with all 16 hemagglutinin (HA) and 9 neuraminidase (NA) types have been isolated from waterfowl or shore birds ([@bib16], [@bib23]). Depending on the virulence of the virus in poultry, isolates from poultry are classified as either low pathogenic (LP) or highly pathogenic (HP) ([@bib1], [@bib9]). LPAIV strains cause asymptomatic to mild respiratory and enteric tract infections while the highly pathogenic strains cause clinical illness and systemic infections. Infections of poultry, especially with the highly pathogenic strains, result in severe economic losses ([@bib8], [@bib48]). Human influenza viruses, including those causing high morbidity and significant mortality, such as the H1N1 from 1918, H2N2 from 1957 and H3N2 from 1968 have been shown to have avian origins ([@bib7], [@bib46]). Even the currently circulating swine origin H1N1 human influenza virus encodes two genes of AIV origin ([@bib2], [@bib17]). Since 1996, highly pathogenic H5N1 AIV strains isolated in Hong Kong have been infecting and subsequently causing deaths in humans, although person-to-person transmission is apparently rare ([@bib7], [@bib35], [@bib51]). Poultry is a logical intermediate host for adaptation of viral strains from wild birds to humans and other mammals, such as swine ([@bib53], [@bib54]). Indeed, human adapted strains have been shown to consist of genome segments of avian, swine and human origin ([@bib53], [@bib54]).

Vaccination efficacy is traditionally determined by the demonstration of protective humoral immunity, especially targeting AIV HA and by putative neutralization of viruses ([@bib9], [@bib43], [@bib45]). While sterile immunity may depend on humoral responses to homologous HA, effector and memory CD8^+^ T cell immunity in mice has been shown to diminish disease preventing mortality, and even morbidity ([@bib37], [@bib44]). Humoral immunity of chickens to AIV is well characterized but little information is available regarding the more difficult to evaluate, viral specific T cell immune responses ([@bib26], [@bib39], [@bib45]). Because mice are not natural hosts of AIV, all the immunological characterization in mice is based only on mouse adapted viruses. It is relevant to define the T lymphocyte mediated immune responses in chickens since AIVs are established pathogens of poultry and can be transmitted directly from chickens to humans.

Avian T lymphocytes have been stimulated *ex vivo* with MHC matched chicken kidney cells (CKC) serving as non-professional antigen presenting cells (APCs) and by the adoptive transfer of MHC matched T lymphocytes to naïve chicks prior to viral challenge ([@bib34], [@bib41]). The availability of a number of poultry lines with defined MHC (located within the chicken B locus) greatly facilitates the evaluation of the adaptive T lymphocyte responses in chickens ([@bib31]). Studies targeting acute infections with a strain of infectious bronchitis virus (IBV), an avian coronavirus, have identified specific CD8^+^ T cell responses ([@bib38]). Adoptive transfer of either effector T cells prepared from birds 10 days post-infection (p.i.) or of memory T lymphocytes prepared from birds 3 weeks after infection with IBV, provided protection against acute disease after viral challenge ([@bib34], [@bib41]). Following infection with H9N2 AIV, [@bib42]) described CD8^+^ T cell responses that correlated with cross-protection to an H5N1 strain. Protection by effector CD8^+^ T lymphocytes prepared at 7 to 10 days p.i. with AIV was demonstrated following adoptive transfer 1 day prior to AIV challenge ([@bib39]). However, none of these studies with AIV identified the individual AIV proteins housing T lymphocytes epitopes or described the kinetics of the T lymphocyte mediated memory responses to AIV.

This current study describes the memory responses of peripheral blood T lymphocytes from chicks to AIV HA and/or NP protein. DNA plasmid vectors expressing AIV proteins were used to delineate the responses induced individually by either HA or NP proteins. Responses were evaluated following *ex vivo* stimulation with MHC-I matched or mismatched APCs. Both NP and HA induced AIV specific memory T lymphocyte responses between 3 and 9 weeks p.i. Although the T lymphocyte response induced by NP was greater than the response induced by HA until 7 weeks p.i., no differences between the responses to the two proteins were detected by 9 weeks p.i. The maximum response of memory T lymphocytes against either AIV NP or HA protein was observed at 5 weeks p.i.

Results {#section0010}
=======

*In vitro* expression of AIV proteins {#section0015}
-------------------------------------

In order to determine the T lymphocyte responses to individual AIV proteins, the NP and HA genes of the low pathogenic H5N9 (Turkey/Wis/68) strain were cloned into the pcDNA3.1/V5-His-TOPO TA vector (Invitrogen, Carlsbad, CA). The eukaryotic expression of the proteins encoded by the plasmids was determined by IFA in CHO-K1 cells 48-h post-transfection with plasmids expressing either NP or HA ([Fig. 1](#fig1){ref-type="fig"} ). No fluorescence was observed in cells transfected with plasmid encoding for LacZ.Fig. 1*In vitro* expression of pcDNA3.1/V5-His-TOPO TA vectored AIV proteins in transfected CHO-K1 cells (magnification, 200 ×). Expression was detected by an IFA using AIV positive reference serum as the source of primary antibodies. Cells were transfected with plasmids expressing (A) LacZ, (B) HA, and (C) NP.

Humoral immune response to AIV proteins {#section0020}
---------------------------------------

The *in vivo* expression of AIV HA and NP and the antibody response to these proteins in the chickens was confirmed by detecting the presence of antibodies specific for HA and NP at 3 weeks p.i. with the plasmids. HI titers of sera from 6 chickens inoculated with the HA expression plasmid using the homologous strain ranged from 5 to 6.5 log~2~ (GMT). Sera from chickens inoculated with HA plasmid failed to inhibit hemagglutination by a heterologous H7N2 AIV. No HI activity was detected in sera of the 4 chickens inoculated with PBS. ELISA titers for antibodies against NP in 6 NP plasmid inoculated chickens ranged between 2.5 and 3.0 log~10~ (GMT) at 3 weeks p.i. ([Fig. 2](#fig2){ref-type="fig"} ).Fig. 2Antibody titers induced in individual birds (*n* = 6) by NP and HA expressing plasmids at 3 weeks p.i. (A) Serum HI antibody titers from chickens inoculated with HA expressing plasmid against the homologous H5N9 AIV strain and heterologous H7N2 AIV strain. (B) Serum anti-NP antibody ELISA titers from chickens inoculated with the NP expressing plasmid. Neither HI nor anti-NP antibodies were detectable in the sera of 4 control birds inoculated with PBS. Each symbol represents the response of an individual chicken.

Memory T cell responses were detected from weeks 3 to 9 p.i. with HA and NP plasmids {#section0025}
------------------------------------------------------------------------------------

Because the T cell specificity for individual AIV proteins have not previously been reported in chickens, T lymphocyte responses to HA, NP or a combination of both HA and NP (HN) were determined following inoculation of B19/B19 chickens with plasmids expressing the HA or NP ORF. In the absence of well-established ELISA or intracellular cytokine staining methods to examine avian T lymphocyte mediated responses an indirect IFNγ assay (NO production from HD11 cells, a chicken macrophage cell line) was precisely standardized for evaluating the *ex vivo* activation of T lymphocytes by APCs. CKC infected with AIV were used as non-professional APCs for the stimulation of T lymphocytes. As demonstrated in other studies, the primary effector T lymphocyte response observed at 10 days p.i. had declined to basal level by 16th day p.i. (data not shown).

Considering previously conducted adoptive transfer studies, which identified specific memory T cells to IBV by 3 weeks p.i. with maximal responses occurring between weeks 5 and 6 p.i. ([@bib34]), the memory AIV response of peripheral blood memory T lymphocytes were also evaluated between 3 and 9 weeks p.i. with HA, NP, or HN plasmids. The kinetics of the T lymphocyte mediated responses was determined on the same birds during the course of the study. All data represent the response from individual birds.

Following *ex vivo* co-culture with MHC matched B19/B19 APCs infected with H5N9 virus, memory responses were detected in T cell preparations obtained from all chickens receiving plasmids expressing either AIV protein by 3 weeks p.i. Since neither supernatants from the T cells cultured with uninfected APCs nor T cells from PBS inoculated birds cultured with infected MHC matched B19/B19 birds produced IFNγ (data not shown), the memory T lymphocyte activity was considered AIV specific. The *ex vivo* stimulation of the T cells from plasmid inoculated birds with MHC mismatched B2/B2 APCs could only induce basal levels of NO ([Fig. 3](#fig3){ref-type="fig"} ), indicating the memory T lymphocyte responses from each group of chickens receiving AIV plasmids was highly MHC restricted.Fig. 3Chicken memory T lymphocyte responses to AIV HA and NP proteins between 3 and 9 weeks p.i. with NP and/or HA expression plasmids. Chickens of the B19/B19 MHC haplotype were inoculated with DNA plasmids expressing AIV HA, NP or both HA and NP (HN). Memory T lymphocytes were stimulated *ex vivo* with H5N9 AIV infected MHC matched B19/B19 and mismatched B2/B2 APCs. Production of NO by HD11 macrophage cells induced by the secretion of IFNγ from stimulated T lymphocytes was used to quantify lymphocyte activation. Results represent the average (± S.E.) of two separate experiments. Each *ex vivo* stimulation assay is denoted by the source of T lymphocytes and MHC haplotype of the APCs infected with the virus. The differences in stimulation by matched and mismatched APCs were significant (*p* ≤ 0.003 to 0.02) for each inoculated antigen and time point. The responses to HN (*p* ≤ 0.03) at 3 weeks and NP (*p* ≤ 0.03) and HN (*p* ≤ 0.007) at 5 weeks p.i. were significantly greater than the responses to HA at the same time points. The *p* value for the difference between responses to NP and HA at 3 weeks p.i. was 0.07.

The maximum memory T cell responses to NP were detected at 5 weeks p.i. However, while still detectable, memory T cells responses at 9 weeks p.i, were dramatically diminished for all birds receiving the AIV expression plasmids (HA, NP or HN). During weeks 3 through 7, the activity of T cells from the HA plasmid inoculated birds was significantly less than that of T cells isolated from birds receiving either NP or NP plus HA plasmids ([Fig. 3](#fig3){ref-type="fig"}). In addition to weaker APC induced stimulation, the levels of HA specific memory T lymphocyte responses were similar at weeks 3, 5 and 7 p.i. These results were observed for two independent experiments.

CD8^+^ T lymphocyte populations increase with *ex vivo* stimulation {#section0030}
-------------------------------------------------------------------

The phenotype of activated subpopulations of T lymphocytes following co-culture with APCs expressing AIV antigens was determined using flow cytometric analyses ([Table 1](#tbl1){ref-type="table"} ). In order to evaluate the type of T lymphocyte population expanding in response to infected APCs, the proliferation of the lymphocytes from chickens inoculated with both NP and HA (HN) plasmids was determined at 5 weeks p.i. Lymphocyte populations were gated using a chicken pan lymphocyte CD44 specific MAb and MAbs specific for either CD4 or CD8 T cell antigens ([@bib38]). The relative increases in the populations of CD8^+^ T lymphocytes harvested from each HA and NP (HN) plasmid inoculated chicken were between 62% and 91% following *ex vivo* stimulation with AIV expressing APCs, in contrast to the increase of 31% to 37% in the CD4^+^ T lymphocyte populations. The increase in the population of T lymphocytes harvested from PBS inoculated birds was 7% and 1% for CD8^+^ and CD4^+^ T lymphocyte subpopulations, respectively, following co-culture with AIV infected APCs. The preferential increase in CD8^+^ cells correlates with their anticipated expansion following exposure to non-professional APCs endogenously expressing AIV and expressing surface MHC-I.Table 1Proliferation of T lymphocytes from birds 5 weeks p.i. with plasmids expressing HA and NP using flow cytometry.[a](#tblfn1){ref-type="table-fn"}Bird no.Inocula[b](#tblfn2){ref-type="table-fn"}CD4^+^ T lymphocytes (% of T cells)CD8^+^ T lymphocytes (% of T cells)Uninfected[c](#tblfn3){ref-type="table-fn"}Infected[d](#tblfn4){ref-type="table-fn"}% Increase[e](#tblfn5){ref-type="table-fn"}UninfectedInfected% Increase1HA+NP47.865.13620.036.4812HA+NP44.059.53524.747.1914HA+NP41.356.63727.043.7625HA+NP46.060.53122.640.4797PBS53.860.8122.424.07[^1][^2][^3][^4][^5]

Responding T cells cross react with a heterologous H7N2 AIV strain {#section0035}
------------------------------------------------------------------

A rationale for targeting cellular immunity is the potential for cross-reactivity between vaccine and heterologous virus. Since the availability of the peripheral T lymphocytes was limited and the same birds were being used throughout the study, all aspects of the memory T lymphocyte mediated responses could not be evaluated at same time points. At 8 weeks p.i. the capacity for memory T lymphocytes specific for the NP and HA proteins of the H5N9 strain to be stimulated with an H7N2 (A/Turkey/Virgina/158512/02) strain of AIV was determined following co-culture with MHC matched APCs infected with either AIV strain ([Fig. 4](#fig4){ref-type="fig"} ). Both heterologous H7N2 and homologous H5N9 AIV infected APCs significantly stimulated IFNγ production from memory T lymphocytes isolated from either HA or NP inoculated chickens (*p*  ≤ 0.01) compared with PBS inoculated chickens. Regardless of the strain used to infect APCs, the observed memory responses generated by T cells obtained from chickens receiving the NP plasmid were again statistically greater (*p*  ≤ 0.008) than that generated by T cells harvested from HA plasmid inoculated chickens.Fig. 4T lymphocytes from B19 birds inoculated with either H5N9 derived HA or NP expression plasmids respond to a heterologous (H7N2) virus. At 8 weeks p.i., T lymphocytes from chickens receiving either HA or NP cloned from the H5N9 strain were co-cultured with APCs infected with H5N9 or H7N2 viruses. The T cell responses are expressed as the average (± S.E.) of NO production for each treatment group. T lymphocytes from plasmid-inoculated chickens had significantly greater responses to H7N2 AIV strain than those from the PBS control group (*p* ≤ 0.01). PBMC were prepared from three individual chickens for each stimulation assay.

Similar memory T lymphocyte responses were observed with low pathogenic AIV infection {#section0040}
-------------------------------------------------------------------------------------

Memory T cells could be readily detected between 3 and 7 weeks p.i. with plasmids expressing either the NP or the HA proteins. In order to evaluate the memory T lymphocyte responses of chickens inoculated with infectious AIV, chicks with the B19/B19 haplotype were inoculated with the low pathogenic H5N9/Turkey/Wis/68 strain and blood was collected at 5 weeks p.i. The *ex vivo* activation of T lymphocytes by AIV infected APCs was determined by the indirect IFNγ assay ([Fig. 5](#fig5){ref-type="fig"} ). The mean average NO production induced by the *ex vivo* stimulation of T lymphocytes from infected birds with B19/B19 APCs was specific compared with the uninfected, MHC matched APCs (*p*  ≤ 0.005). The responses to AIV infected APCs were MHC restricted as demonstrated by only basal level activation by B2/B2 APCs.Fig. 5*In vivo* infection of B19 chickens with the low path H5N9/Tur/Wis/68 AIV generates AIV specific, MHC matched memory T lymphocytes. The potential for infectious AIV to also produce a memory T lymphocyte response was determined 5 weeks p.i. with H5N9. Mean (±S.E.) NO production by each treatment group is represented by the bars. APCs used for *ex vivo* stimulation were either uninfected (Uninf) or virus-infected (Inf). Significantly lower (*p* ≤ 0.01) NO production by AIV infected mismatched APCs derived from the CKC of homozygous B2 chicks compared to matched APCs derived from CKC of homozygous B19 chicks indicate MHC restriction. T lymphocytes from three individual birds were used for each *ex vivo* stimulation assay.

Flow cytometric analysis was used to determine the phenotype of the T lymphocyte subpopulations from the infected chickens responding to *ex vivo* stimulation. The relative increase in the population of CD8^+^ T lymphocytes from H5N9 infected chickens was 46% to 95% while the increase in the CD4^+^ T lymphocyte population ranged from 6 to 28% following co-culture with MHC-I matched, H5N9 AIV infected APCs ([Table 2](#tbl2){ref-type="table"} ). The increase in the population of the lymphocytes from uninfected chickens was only 1 to 14% and 10 to 19% for CD8^+^ and CD4^+^ T lymphocytes, respectively. Although increases were observed in the CD4^+^ lymphocytes, the greater increased proliferation of CD8^+^ lymphocytes from birds infected with the low pathogenic virus was consistent with detection of a preferential MHC-I restricted AIV specific, CD8^+^ memory T cell response.Table 2Proliferation of T lymphocytes from birds 5 weeks p.i. with AIV using flow cytometry.Bird no.CD4^+^ T lymphocytes (% of T cells)CD8^+^ T lymphocytes (% of T cells)Uninfected[a](#tblfn6){ref-type="table-fn"}Infected[b](#tblfn7){ref-type="table-fn"}% Increase[c](#tblfn8){ref-type="table-fn"}UninfectedInfected% IncreaseI-1[d](#tblfn9){ref-type="table-fn"}40.752.12816.331.795I-248.358.42112.120.569I-349.660.92317.825.946I-455.959.5618.531.771I-543.953.6229.5518.594C-1[e](#tblfn10){ref-type="table-fn"}42.550.71927.928.11C-239.243.11010.812.314[^6][^7][^8][^9][^10]

Discussion {#section0045}
==========

This is the first study delineating the response of chicken memory CD8^+^ T lymphocytes to specific AIV proteins. Studies evaluating the CD8^+^ T lymphocyte response to influenza virus in mice have identified NP as housing the dominant CD8^+^ T cell epitopes ([@bib15], [@bib24], [@bib33], [@bib50], [@bib55]). In contrast, human cytotoxic T lymphocytes (CTL) have a broader repertoire and the response is directed to multiple influenza viral proteins, including HA ([@bib18], [@bib19], [@bib20], [@bib22], [@bib25]). This study has shown that similar to the responses in humans, memory CD8^+^ T lymphocytes in chickens are directed against both AIV HA and NP proteins ([@bib18], [@bib20], [@bib25], [@bib30]). Significantly greater responses were induced by NP than by HA at 3 and 5 weeks p.i. The AIV specific T cell responses were primarily MHC-I restricted as non-professional APCs of B19 and B2 haplotypes were used for *ex vivo* stimulation of T cells and the APCs of B2 haplotype chickens either failed to stimulate or could only weakly stimulate the T lymphocytes derived from the B19 line. Therefore, responding T cells were primarily of the CD8^+^ phenotype, which also showed significantly greater proliferation than CD4^+^ T lymphocytes in response to *ex vivo* APC mediated stimulation. Similar to the MHC-I restricted T lymphocyte responses demonstrated following infection with IBV, CD8^+^ T cell memory responses to AIV HA and/or NP were detected by 3 weeks p.i. ([@bib34]). Preliminary studies in our lab have also demonstrated an elevation in the levels of expression of CD44 molecule on the surface of the responding T lymphocytes. Greater CD44 expression has been described to be a characteristic of mouse and human memory T lymphocytes ([@bib12]).

The current studies quantified the protein specific T lymphocyte responses of the same birds until 9 weeks p.i. The responses increased from 3 weeks p.i. until 5 weeks p.i. However, by 9 weeks p.i. with plasmids expressing either NP or HA AIV protein, the memory T cell activity had declined to significantly lower levels. The decline in the more vigorous CD8^+^ T lymphocyte response to NP was more rapid after 5 weeks than the CD8^+^ T cell response stimulated by HA, such that by 9 weeks p.i. the responses to both proteins individually or in combination were similar. A decline in the CD8^+^ T lymphocyte mediated protection at 10 weeks after challenge of H9N2- infected chicks with H5N1 had been observed by [@bib39]). Similarly, a decline in the memory T lymphocyte response specific to influenza virus infection has also been reported in humans ([@bib28]).

Furthermore, our study also proved the efficacy of the plasmid delivery approach in providing a mechanism to evaluate the T cell response to AIV HA and NP proteins, either individually or in combination. Protection studies were not included following inoculation of the AIV plasmids because of increased biosafety requirements for AIV. However, hemagglutinating antibodies which can be correlated with protection were demonstrated ([@bib49]). The antibodies specific for the HA cloned from a H5N9 virus failed to prevent H7N2 virus-mediated hemagglutination.

Since each *ex vivo* stimulation assay required specific numbers of necessary controls for the validity of the results of the assay and availability of limited numbers of T lymphocytes for each time, all assays could not be conducted at the same time point. Although at 8 weeks p.i. the response of the memory T lymphocytes was significantly lower than the response at 5 weeks p.i., it remained detectable and the APCs infected with H7N2 AIV were able to effectively *ex vivo* stimulate the T lymphocytes from H5 inoculated chickens. These observations indicate that despite the absence of shared HI antibody epitopes, HA does have at least one CD8^+^ epitope that is shared between both strains of the virus.

Adoptive transfer studies of CD8^+^ T lymphocytes specific for IBV and AIV have demonstrated their importance in protection against heterologous viruses ([@bib34], [@bib41], [@bib39]). In mice, adoptive transfer of memory CD8^+^ T lymphocytes specific for influenza virus NP has also been shown to be protective against viral challenge ([@bib27], [@bib47]). *In vivo* inoculation of chicks with a DNA plasmid expressing the IBV nucleocapsid protein was shown to provide CTL mediated protection against acute respiratory disease ([@bib40]). Consistent with the greater response to NP from the homologous virus, T lymphocytes of chicks inoculated with NP exhibited greater cross reactivity with the heterologous H7N2 virus than T cells from the birds inoculated with HA. The amino acid sequences in HA from the two AIV strains were 41% identical while the amino acid sequences of NP were 97% identical. The more conserved nature of NP, in comparison to HA could be responsible for the greater cross reactive response ([@bib36]). Although the variation could also be attributed to the differences in the amount of antigen generated and presented by the infected APCs ([@bib5], [@bib11], [@bib13], [@bib14]), both NP and HA responses were similar by 9 weeks p.i. using the same standardized cell assay.

The differences in the repertoire of T cell epitopes along with the variations in the binding affinity of T cell epitopes with MHC-I can also contribute to the differences in the CD8^+^ T cell mediated response to influenza viral proteins ([@bib6], [@bib29]). Chickens have 27 distinct defined MHC haplotypes ([@bib31]). Further studies aimed at determining the response to AIV proteins in different MHC lines of chickens is important for identification of immunodominant proteins which can elicit conserved CD8^+^ T lymphocyte responses amongst various MHC haplotypes.

Although the cross reactivity of memory CD8^+^ T lymphocytes may not prevent the infection of chickens with a heterotypic strain of AIV, it could contribute to the more rapid clearance of the virally infected cells and augment the protection against clinical illness. This study establishes that chickens CD8^+^ T lymphocytes respond to AIV NP and HA proteins. The ability of the other AIV proteins to stimulate CD8^+^ T lymphocytes of chickens needs to be evaluated. Future experiments would also analyze the expression of various cytokines by the activated T lymphocytes. Inclusion of AIV protein targets that can induce cross reactive CD8^+^ T lymphocyte responses in addition to humoral immunity in chickens is critical for the development of efficacious vaccines which can provide protective immunity against a broader range of AIV types.

Materials and methods {#section0050}
=====================

Viruses {#section0055}
-------

Low pathogenic AIVs, H5N9 (A/Turkey/Wis/68) and H7N2 (A/Turkey/Virginia/158512/02), were propagated in the allantoic sacs of 10-day-old embryonated chicken eggs (ECE). The allantoic fluid was harvested 48 h p.i. and the presence of virus was verified by an hemagglutination activity (HA) test according to the OIE guidelines (<http://www.oie.int/eng/normes/mmanual/2008/pdf/2.03.04_AI.pdf>). Viruses were quantified by titrating in ECE and expressed as embryo infectious dose 50 (EID~50~) ([@bib3]).

Experimental animals {#section0060}
--------------------

Embryonated eggs of MHC defined B19/B19 and B2/B2 lines of chickens were obtained from Dr. Briles\' laboratory at Northern Illinois University (DeKalb, IL). After hatching, chicks were housed in a specific pathogen-free environment at the vivarium facility, Western University of Health Sciences, Pomona, CA. Viral infection studies in chickens were conducted at the biosafety level 2 Lab Animal Research Resource animal facility, Texas A&M University, College Station, TX. All procedures involving the use of chickens were approved by and conducted according to guidelines established by the Institutional Animal Care and Use Committees of Western University of Health Sciences and/or Texas A&M University.

Cloning of NP and HA into a eukaryotic expression plasmid {#section0065}
---------------------------------------------------------

RNA from H5N9 (A/Turkey/Wis/68) was extracted from allantoic fluid using the RNeasy Mini kit (Qiagen, Valencia, CA) according to the manufacturer\'s protocol. First strand cDNA was synthesized with ImProm-II™ Reverse Transcriptase enzyme (Promega, Madison, WI) using AIV specific Universal 12 primer (5′AGCA/GAAAGCAGG 3′)([@bib52]). PFU polymerase (Stratagene, La Jolla, CA) was used to amplify the open reading frames (ORF) of HA and NP using specific primer pairs HA-Forward 5′-ACCATGGAAAGAATAGTGATT-3′and HA-Reverse 5′-GATGCAAATTCTGCA-3′ and NP-Forward 5′-ACCATGGCGTCTCAAGGCACC-3′ and NP-Reverse 5′-ATTGTCATACTCCTCTGC-3′, respectively. Taq DNA polymerase (New England Biolabs, Ipswich, MA) was then used to add TA overhangs on the PFU amplified PCR product. The amplified cDNA products were cloned into the eukaryotic expression vector pcDNA3.1/V5-His-TOPO TA (Invitrogen, Carlsbad, CA). Big Dye terminator v1.1cycle sequencing kit (Applied Biosystems, Foster City, CA) was used to sequence the cloned gene segments and the sequence analysis was performed at GenoSeq, UCLA, Los Angeles, CA. Following confirmation of the sequence of the ORFs, *in vitro* expression of NP and HA proteins were determined using an indirect immunofluorescence assay (IFA) on CHO-K1 cells transfected with the plasmids expressing AIV proteins. Known chicken serum, positive for AIV (NVSL, Ames, IA) was used at a dilution of 1:100 as primary antibody. Mouse anti-chicken IgG FITC at a dilution of 1:500 (Southern Biotech, Birmingham, AL) was used as the secondary antibody.

Generation of APCs {#section0070}
------------------

Primary CKC lines were established from 10-day-old chicks of B19/B19 and B2/B2 MHC haplotype lines as described previously ([@bib38]). CKC of the tenth passage were infected with AIV and used as non-professional APCs for the stimulation of the CD8^+^ T lymphocytes. The presence of MHC-I on CKC lines and the absence of MHC-II was confirmed by flow cytometric analysis, using anti-chicken MHC-I or anti-chicken MHC-II R-phycoerythrin conjugated monoclonal antibodies (MAbs) (Southern Biotech, Birmingham, AL) (data not shown).

Inoculation of birds {#section0075}
--------------------

Three-week-old specific, pathogen-free chickens of the B19/B19 MHC haplotype were inoculated, intramuscularly (i.m.), with 500 μg of cDNA expressing HA alone or NP alone, or of 500 μg of each HA and NP (HN) combined. Control birds were inoculated with either pcDNA 3.1 vector expressing LacZ (LacZ) or PBS. For viral inoculations, B19/B19 chicks were inoculated at 3 weeks of age, intranasally, with 10^8^ ELD~50~ of the low pathogenic H5N9/Tur/Wis/68 AIV strain.

AIV-specific antibody titrations {#section0080}
--------------------------------

Serum samples were prepared from blood collected from the jugular vein of chickens at 3 weeks p.i. to evaluate the humoral responses against AIV HA and NP. Hemagglutination inhibition (HI) assays, according to OIE guideline (<http://www.oie.int/eng/normes/mmanual/2008/pdf/2.03.04_AI.pdf>), were used to identify antibodies specific to H5N9 virus (A/Turkey/Wis/68) HA. HI mediated by the anti-H5 antibodies against H7N2 AIV was also evaluated. Titers were expressed as geometric mean titers (GMT). Titers of ≤ 1 log~2~were assigned a titer of 1 log~2~. NP specific antibodies were determined using the AIV Plus ELISA kit (Synbiotics, Kansas City, MO) as described by the manufacturer.

Effector cell preparation {#section0085}
-------------------------

Effector T lymphocytes used for *ex vivo* stimulation were prepared from peripheral blood mononuclear cells (PBMC) from 2 to 4 individual chickens per group ([@bib34]). Briefly, blood was collected from the jugular vein at 3, 5, 7 and 9 weeks p.i. and diluted 1:2 in Alsever\'s solution (Sigma-Aldrich, St. Louis, MO). PBMC were prepared by Ficoll-histopaque (Histopaque-1077, Sigma-Aldrich, St. Louis, MO) density gradient centrifugation ([@bib38]). Viable cells were collected from the interface and washed twice with phosphate buffered saline (PBS, pH 7.4). Cells were resuspended in 3 ml of RPMI 1640 (Invitrogen, La Jolla, CA) supplemented with 10% fetal bovine serum (Gemini Bio-Products, West Sacramento, CA), 2 mM [l]{.smallcaps}-glutamine, and 0.1 mM MEM non-essential amino acids. B lymphocytes were removed by passing the cell suspension through complete RPMI equilibrated nylon wool column and adherent cells were removed by incubating the cell preparation in 25 cm^2^ tissue culture flasks as described previously ([@bib38]). Flow cytometric analysis of cells labeled with anti-chicken CD3 FITC MAbs (Southern Biotech, Birmingham, AL) as described previously determined that the lymphocyte population recovered after nylon wool separation and removal of adherent cells was 97% positive for the expression of the T lymphocyte marker, CD3 ([@bib4]).

*Ex vivo* stimulation of T lymphocytes {#section0090}
--------------------------------------

T lymphocytes from PBMC were stimulated *ex vivo* with MHC B19/B19 (matched) and B2/B2 (mismatched) APCs. APCs at a concentration of 1 × 10^5^ cells/ml in 96-well tissue culture plates were incubated for 8 h at 39 °C, 5% CO~2~. APCs were infected with 1x10^5^ ELD~50~ of H5N9 (A/Turkey/Wis/68) virus for 1 h followed by removal of the virus and cells before washing 3 times with DMEM supplemented with 10% FBS. One × 10^6^ T lymphocytes in complete RPMI were added to each well. Cells were co-cultured for 24 h, before the media was collected and centrifuged. The clarified supernatants were used to quantify IFNγ production by activated T lymphocytes using a nitric oxide detection assay. At 5 weeks p.i. the pelleted T lymphocytes were collected for FACS analysis to measure the lymphocyte proliferation. Each *ex vivo* stimulation assay was conducted in duplicate.

Nitric oxide induction assay {#section0095}
----------------------------

A modified indirect IFNγ assay based on NO production ([@bib10], [@bib21], [@bib34]) from HD11 cells (a chicken macrophage cell line) was used to quantify the IFNγ secreted from *ex vivo* activated T lymphocytes by APCs. Briefly, cells were incubated in individual wells of 96-well plates at a concentration of 1 × 10^5^ cells/well in complete RPMI media for 2 h at 39 °C, 5% CO~2~ prior to the addition of 150 μl supernatants from T lymphocyte-APCs cultures. After 24 h of incubation, the accumulation of nitrite in supernatant from stimulated HD11 cells was measured using the Griess reagent assay according to the manufacturer\'s protocol (Sigma-Aldrich, St. Louis, MO). To ensure that the data represent the nitric oxide produced specifically by the IFNγ mediated stimulation of HD11 cells and not due to any other soluble inducing factors, nitrite concentration in each sample was normalized by subtracting the nitrite concentration of supernatants from control APCs cultured without T lymphocytes. The concentration of nitrite produced was determined using sodium nitrite solutions with a concentration of 1 to 20 μmol as standards.

FACS analysis {#section0100}
-------------

After *ex vivo* stimulation with AIV infected APCs, T lymphocytes were collected and dual labeled with phycoerythrin-conjugated MAbs specific for CD44 and fluorescein labeled MAbs specific for either CD8 or CD4 (Southern Biotech Birmingham, AL) as previously described ([@bib38]). Flow cytometric analysis was used to determine the concentration of T lymphocyte subpopulations. A minimum of 10^4^ events were collected for each sample. The percentage of CD44^+^ lymphocytes expressing either CD4 or CD8 surface antigen was determined using FlowJo™ (TreeStar, Inc., Ashland, OR). Cell proliferation was calculated as the percent increase in the population of CD4^+^ or CD8^+^ T lymphocytes cultured with uninfected APCs after *in vitro* stimulation by virus-infected APCs for 24 h.

Statistical significance of differences {#section0105}
---------------------------------------

The nitric oxide concentrations were expressed as the average of 4 to 6 birds per group. ANOVA (analysis of variance) with significance of *p*  ≤ 0.05 was used to determine statistical differences.
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[^1]: Data representative of 2 experiments.

[^2]: HA + NP-Birds inoculated with 500 μg plasmids expressing HA and NP (HN) or PBS only.

[^3]: Population of T lymphocytes after stimulation with uninfected APCs.

[^4]: Population of T lymphocytes after stimulation with infected APCs.

[^5]: Increase in the population of T lymphocytes following stimulation by APCs expressing AIV.

[^6]: Population of T lymphocytes after stimulation with uninfected APCs.

[^7]: Population of T lymphocytes after stimulation with infected APCs.

[^8]: Increase in the population of T lymphocytes following stimulation with APCs expressing AIV.

[^9]: I---Chickens infected with H5N9/Turkey/Wis/68 AIV.

[^10]: C---Control chickens inoculated with PBS.
